BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17875677)

  • 1. Myosin IIA is required for cytolytic granule exocytosis in human NK cells.
    Andzelm MM; Chen X; Krzewski K; Orange JS; Strominger JL
    J Exp Med; 2007 Oct; 204(10):2285-91. PubMed ID: 17875677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity.
    Sanborn KB; Mace EM; Rak GD; Difeo A; Martignetti JA; Pecci A; Bussel JB; Favier R; Orange JS
    Blood; 2011 Nov; 118(22):5862-71. PubMed ID: 22123909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosin IIA associates with NK cell lytic granules to enable their interaction with F-actin and function at the immunological synapse.
    Sanborn KB; Rak GD; Maru SY; Demers K; Difeo A; Martignetti JA; Betts MR; Favier R; Banerjee PP; Orange JS
    J Immunol; 2009 Jun; 182(11):6969-84. PubMed ID: 19454694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion.
    Iizuka Y; Cichocki F; Sieben A; Sforza F; Karim R; Coughlin K; Isaksson Vogel R; Gavioli R; McCullar V; Lenvik T; Lee M; Miller J; Bazzaro M
    J Immunol; 2015 Nov; 195(10):4760-70. PubMed ID: 26438524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
    Schmidt RE; Caulfield JP; Michon J; Hein A; Kamada MM; MacDermott RP; Stevens RL; Ritz J
    J Immunol; 1988 Feb; 140(3):991-1002. PubMed ID: 3276787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat-killed Lactobacillus acidophilus La205 enhances NK cell cytotoxicity through increased granule exocytosis.
    Cheon S; Lee KW; Kim KE; Park JK; Park S; Kim CH; Kim D; Lee HJ; Cho D
    Immunol Lett; 2011 May; 136(2):171-6. PubMed ID: 21256158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas Ligand localizes to intraluminal vesicles within NK cell cytolytic granules and is enriched at the immune synapse.
    Lee J; Dieckmann NMG; Edgar JR; Griffiths GM; Siegel RM
    Immun Inflamm Dis; 2018 Jun; 6(2):312-321. PubMed ID: 29642281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function.
    Phatarpekar PV; Billadeau DD
    J Cell Sci; 2020 Feb; 133(5):. PubMed ID: 32086255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Killer Cell Group 7 Sequence in Cytotoxic Cells Optimizes Exocytosis of Lytic Granules Essential for the Perforin-Dependent, but Not Fas Ligand-Dependent, Cytolytic Pathway.
    Morikawa Y; Murakami M; Kondo H; Nemoto N; Iwabuchi K; Eshima K
    Immunohorizons; 2021 Apr; 5(4):234-245. PubMed ID: 33911019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis.
    Tanaka T; Porter CM; Horvath-Arcidiacono JA; Bloom ET
    Int Immunol; 2007 Feb; 19(2):163-73. PubMed ID: 17182966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoscale Dynamism of Actin Enables Secretory Function in Cytolytic Cells.
    Carisey AF; Mace EM; Saeed MB; Davis DM; Orange JS
    Curr Biol; 2018 Feb; 28(4):489-502.e9. PubMed ID: 29398219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.
    Gil-Krzewska A; Saeed MB; Oszmiana A; Fischer ER; Lagrue K; Gahl WA; Introne WJ; Coligan JE; Davis DM; Krzewski K
    J Allergy Clin Immunol; 2018 Sep; 142(3):914-927.e6. PubMed ID: 29241728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligation of ICAM-1 molecules inhibits target cell-induced granule exocytosis of IL-12-activated natural killer cells.
    Cho DH; Song HK; Kang HS; Yoon SR; Lee HG; Pyun KH; Lee WJ; Kim YB; Choi I
    Cell Immunol; 2000 Jan; 199(1):1-7. PubMed ID: 10675269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arf-like GTPase Arl8b regulates lytic granule polarization and natural killer cell-mediated cytotoxicity.
    Tuli A; Thiery J; James AM; Michelet X; Sharma M; Garg S; Sanborn KB; Orange JS; Lieberman J; Brenner MB
    Mol Biol Cell; 2013 Dec; 24(23):3721-35. PubMed ID: 24088571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WIP is essential for lytic granule polarization and NK cell cytotoxicity.
    Krzewski K; Chen X; Strominger JL
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2568-73. PubMed ID: 18258743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VAMP4- and VAMP7-expressing vesicles are both required for cytotoxic granule exocytosis in NK cells.
    Krzewski K; Gil-Krzewska A; Watts J; Stern JN; Strominger JL
    Eur J Immunol; 2011 Nov; 41(11):3323-9. PubMed ID: 21805468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid activation receptor- or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signaling.
    James AM; Hsu HT; Dongre P; Uzel G; Mace EM; Banerjee PP; Orange JS
    Blood; 2013 Apr; 121(14):2627-37. PubMed ID: 23380740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity.
    Krzewski K; Gil-Krzewska A; Nguyen V; Peruzzi G; Coligan JE
    Blood; 2013 Jun; 121(23):4672-83. PubMed ID: 23632890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granule-Dependent NK Cell Killing of Cryptococcus Requires Kinesin to Reposition the Cytolytic Machinery for Directed Cytotoxicity.
    Ogbomo H; Timm-McCann M; Barnes T; Xiang RF; Jamil K; Ganguly A; Stack D; Huston SM; Li SS; Colarusso P; Mody CH
    Cell Rep; 2018 Sep; 24(11):3017-3032. PubMed ID: 30208325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VASP Regulates NK Cell Lytic Granule Convergence.
    Wilton KM; Billadeau DD
    J Immunol; 2018 Nov; 201(10):2899-2909. PubMed ID: 30282752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.